4 Females should be either of non-childbearing potential defined as having undergone surgical sterilization or postmenopausal age 50 and amenorrheic for 12 months or of childbearing potential Females of childbearing potential must have a negative serum beta-human chorionic gonadotropin ?-hCG at Visit 1 and a negative urine pregnancy test prior to randomization at Visit 2 Female subjects of childbearing potential must agree to be abstinent or to use at least 1 medically acceptable method of contraception eg a double-barrier method eg condom spermicide condom diaphragm with spermicide IUD or have a vasectomised partner starting at Visit 1 and throughout the entire study period and for 2 months after the last dose of study drug Those women using hormonal contraceptives must also be using an additional approved method of contraception as described previously starting at Visit 1 and continuing throughout the entire study period and for 2 months after the last dose of study drug It is not required for male subjects to use contraceptive measures based on preclinical toxicology data 